Zydus Lifesciences gets USFDA nod for Pulmonary Arterial Hypertension drug Selexipag Ruchika Sharma6 May 2022 3:03 PM ISTThe drug will be manufactured at group’s formulation facility at SEZ, Ahmedabad.
Dr. Roddy's gets CDSCO panel nod to manufacture & market Treprostinil solution for Infusion Dr. Divya Colin12 March 2022 1:51 PM ISTNew Delhi: Granting a local clinical trial waiver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
Study details HIV-associated pulmonary arterial hypertension and its impact on HIV management Medha Baranwal5 Feb 2022 9:00 AM ISTUSA: At any stage of human immunodeficiency virus (HIV) infection, HIV-associated pulmonary arterial hypertension (PAH) can occur, independent of CD4...
Alembic Pharma Selexipag bags USFDA okay Roshni Dhar9 Dec 2021 5:50 PM ISTDrugmaker, Alembic Pharmaceuticals Limited, announced that the company has received tentative approval from the US Food & Drug Administration...
Health Bulletin 9/December/2021 Roshni Dhar9 Dec 2021 5:37 PM ISTHere are Top Health stories of the dayNEET PG Counselling Delay: Health Ministry Urges SC for Speedy Hearing, Doctors warn of protest...
Alembic Pharma gets USFDA nod for pulmonary arterial hypertension drug Selexipag Ruchika Sharma8 Dec 2021 3:14 PM ISTMumbai: Drugmaker, Alembic Pharmaceuticals Limited, today announced that the company has received tentative approval from the US Food & Drug...
Macitentan improves Cardiopulmonary structure and function in PAH patients MD Editorial Team7 Dec 2021 9:00 AM ISTA recent study found that Macitentan medication resulted in significant and clinically important improvements in right ventricular (RV) function and...
FDA Approves IV Formulation of Uptravi for Pulmonary Arterial Hypertension Hina Zahid4 Aug 2021 3:46 PM ISTUSA: The US Food and Drug Administration (FDA) has approved intravenous (IV) formulation of Uptravi (selexipag) injection for the treatment of...
Janssen Pharma Selexipag gets USFDA nod to treat pulmonary arterial hypertension Ruchika Sharma2 Aug 2021 12:15 PM ISTTitusville: The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the U.S. Food and Drug Administration (FDA) has...
Zydus Macitentan gets USFDA okay, eligible for 180 days of shared generic drug exclusivity Ruchika Sharma8 April 2021 12:20 PM ISTAhmedabad: Pharma major, Zydus Cadila, today announced that the company has received final approval from the United States Food and Drug...
Alembic Pharma arm gets USFDA nod for Treprostinil Injection Ruchika Sharma13 Feb 2021 3:29 PM ISTTreprostinil Injection is indicated for the treatment of pulmonary arterial hypertension (PAH;WHO Group 1) to diminish symptoms associated with...
Obesity may worsen quality of life in patients with PAH, Study finds Dr. Nandita Mohan27 Jan 2021 7:01 AM ISTResearchers have found in a new study that Patients with pulmonary arterial hypertension who were also overweight or obese had a higher incidence of...
